Table 3.
Unconditional Growth Models
| Measure | Estimate | SE | t | df | p |
|---|---|---|---|---|---|
| SIGH-A | |||||
| Intercept (MA2) | 11.35 | .45 | 25.00 | 255 | <.0001 |
| Slope over Time (MA2-MA4) | −.16 | .03 | −5.65 | 351 | <.0001 |
| PDSS | |||||
| Intercept (MA2) | 6.51 | .26 | 24.85 | 255 | <.0001 |
| Slope over Time (MA2-MA4) | −.13 | .02 | −7.89 | 367 | <.0001 |
| SIGH-D | |||||
| Intercept (MA2) | 7.64 | .34 | 22.18 | 255 | <.0001 |
| Slope over Time (MA2-MA4) | −.10 | .02 | −4.27 | 351 | <.0001 |
| WSAS | |||||
| Intercept (MA2) | 5.60 | .36 | 15.51 | 251 | <.0001 |
| Slope over Time (MA2-MA4) | −.08 | .02 | −3.55 | 320 | .0004 |
Note. MA2 assessment occurred post-acute treatment. MA2-MA4 is the period following post-acute-treatment. Intercept refers to the estimated score of each measure at MA2. Slope estimates refer to changes in the score of each measure per month during MA2-MA4.